Herantis Pharma Oyj (HEL: HRTIS)

Market Cap	24.80M
Revenue (ttm)	n/a
Net Income (ttm)	-612.16K
Shares Out	20.16M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,105
Open	1.220
Previous Close	1.220
Day's Range	1.210 - 1.260
52-Week Range	1.170 - 1.880
Beta	0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 22, 2024

About Herantis Pharma Oyj

Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying cerebral dopamine neurotrophic factor (CDNF) based therapies for Parkinson’s disease (PD). Its lead product in pipeline includes HER-096, an advanced small synthetic chemical peptidomimetic molecule developed based on the active site of the CDNF protein for the treatment of PD and other neurodegenerative diseases. The company was incorporated in 2008 and is based in Espoo, Finland.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 10
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: HRTIS